Koers Acerus Pharmaceuticals Corporation Toronto S.E.
Aandelen
ASP
CA00444G4051
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01-05-18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09-09-13 |
Borys Chabursky
BRD | Director/Board Member | - | 20-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,03% | 701 mld. | |
+26,24% | 571 mld. | |
+1,14% | 381 mld. | |
+20,84% | 334 mld. | |
+17,05% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-2,59% | 157 mld. |